Sebia invites you to their event

Free Light Chains: Is the "Gold Standard" Still Really a Standard?

July 01, 2025 17:00 (CEST)
About 1 hour

About this event

Abstract

In this 60-minute webinar, Pr. Oliver Frey will notably:

  • Introduce plasma cell neoplasms and other diseases with paraprotein
  • Explain the role of free light chains (FLC) in diagnosis and follow-up of plasma cell neoplasms
  • Give an overview on available free light chain assays: technical and methodological aspects
  • Outline what is important in selecting a FLC assay: reference interval, CKD, clinical performance
  • Detail lessons learned when switching FLC assays

Speaker's biography

Pr. Oliver Frey is a specialist in laboratory medicine.

He is medical director of the IMD Berlin MVZ and specializes in immunological diagnostics and the diagnosis of hematological neoplasia.

Pr. Frey is also involved in accreditation procedures as an expert assessor in the field of immunology and is committed to quality-assured, precise and patient-centered medical diagnostics.

Hosted by

  • Guest speaker
    G
    Oliver Frey Specialist in Laboratory Medicine @ IMD Berlin MVZ

  • Team member
    T
    Raphael Kech Global Product Manager @ Sebia, France

Sebia

The new language of Life

Sebia is the world’s leading provider of clinical protein electrophoresis equipment and reagents, a technology used for in-vitro diagnostic (IVD) testing.

Host webinars on Host webinars on Livestorm
Virtual Meetings ∙ Webinars ∙ Virtual Events ∙ On-Demand Webinars ∙ Automated Webinars ∙ Product Demos ∙ Company communication ∙ Customer training ∙ Live Q&As ∙ Employee onboarding ∙ Live events
body{font-family: 'Poppins', sans-serif;}